Additionally, these researchers demonstrated that COL3A1 expression was substantially correlated with age, sex, stage, T stage, Dukes stage, tobacco use, recurrence, and survival status in various cohorts of patients with CRC. This evidence concerns the gene COL3A1 and colorectal carcinoma.